MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/biomedicines9111584

Медицинская библиотека · Biomedicines · 2021

Pre-Existing Humoral Immunological Memory Is Retained in Patients with Multiple Sclerosis Receiving Cladribine Therapy.

Moser Tobias, O'Sullivan Ciara, Puttinger Christian, Feige Julia, Pilz Georg, Haschke-Becher Elisabeth, Cadamuro Janne, Oberkofler Hannes, Hitzl Wolfgang, Harrer Andrea, Kraus Jörg, Trinka Eugen, Wipfler Peter

СтатьяПеревод в очереди

Аннотация

Cladribine (CLAD) is a lymphodepleting agent approved for active relapsing multiple sclerosis (MS). The impact of CLAD on the adaptive humoral immune system has not sufficiently been studied. This study aimed to assess the influence of CLAD treatment on specific antibody titers to common pathogens. We included 18 MS patients treated with CLAD. Serum IgG antibody levels to measles, mumps, rubella, hepatitis B and varicella zoster virus (VZV), as well as diphtheria and tetanus toxins, were measured prior to the initiation of treatment and at 12 and 24 months after first CLAD administration. Moreover, specimens were longitudinally analyzed regarding absolute blood concentrations of IgG and main lymphocyte subsets. No reduction in antibody levels against measles, mumps, rubella, VZV, hepatitis B, diphtheria toxin and tetanus toxin associated with CLAD treatment was observed. Loss of seroprotection occurred in <1%. We found no significant impact of CLAD on absolute serum IgG levels. Absolute lymphocyte counts were significantly reduced at the end of each treatment year (p < 0.00001 and p < 0.000001). This study suggests that CLAD does not interfere with the pre-existing humoral immunologic memory in terms of pathogen-specific antibody titers.

Для цитирования: Moser Tobias, O'Sullivan Ciara, Puttinger Christian, Feige Julia, Pilz Georg, Haschke-Becher Elisabeth, Cadamuro Janne, Oberkofler Hannes, Hitzl Wolfgang, Harrer Andrea, Kraus Jörg, Trinka Eugen, Wipfler Peter. Pre-Existing Humoral Immunological Memory Is Retained in Patients with Multiple Sclerosis Receiving Cladribine Therapy.. Biomedicines. 2021. DOI: 10.3390/biomedicines9111584.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.